{
    "clinical_study": {
        "@rank": "24970", 
        "arm_group": [
            {
                "arm_group_label": "Active TES", 
                "arm_group_type": "Active Comparator", 
                "description": "Active TES"
            }, 
            {
                "arm_group_label": "Sham TES", 
                "arm_group_type": "Sham Comparator", 
                "description": "Sham TES"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is a RCT of transcranial electrical stimulation in depressed patients. Mood,\n      cognitive test performance and biomarkers will be measured during the trial."
        }, 
        "brief_title": "Transcranial Electrical Stimulation (TES) for the Treatment of Depression.", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Major Depression", 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder", 
                "Depressive Disorder, Major"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  DSM-IV Major Depressive Episode (as part of a Major Depressive Disorder or  Bipolar\n             Disorder), of minimum 4 weeks duration.\n\n          -  MADRS score \u2265 20 at study entry.\n\n        Exclusion Criteria:\n\n          -  DSM-IV psychotic disorder;\n\n          -  drug or alcohol abuse or dependence (preceding 12 months);\n\n          -  inadequate response to ECT (current episode of depression);\n\n          -  anticonvulsant or benzodiazepine medication;\n\n          -  rapid clinical response required, e.g. high suicide risk; clinically defined\n             neurological disorder or insult;\n\n          -  metal in the cranium, skull defects, or skin lesions on scalp (cuts, abrasions, rash)\n             at proposed electrode sites;\n\n          -  pregnancy."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "75", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01792414", 
            "org_study_id": "HC12143"
        }, 
        "intervention": [
            {
                "arm_group_label": "Sham TES", 
                "description": "Neuroconn Eldith device", 
                "intervention_name": "Sham TES", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Active TES", 
                "description": "Neuroconn Eldith device", 
                "intervention_name": "Active TES", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 30, 2014", 
        "location": {
            "contact": {
                "email": "a.alonzo@unsw.edu.au", 
                "last_name": "Angelo Alonzo, PhD", 
                "phone": "61-2-93823720"
            }, 
            "contact_backup": {
                "email": "donel.martin@unsw.edu.au", 
                "last_name": "Donel Martin, PhD", 
                "phone": "61-2-93829261"
            }, 
            "facility": {
                "address": {
                    "city": "Sydney", 
                    "country": "Australia", 
                    "state": "New South Wales", 
                    "zip": "2031"
                }, 
                "name": "Black Dog Institute / University of New South Wales"
            }, 
            "investigator": {
                "last_name": "Colleen Loo, MBBS, FRANZCP, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Australia"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "a.alonzo@unsw.edu.au", 
            "last_name": "Angelo Alonzo, PhD", 
            "phone": "61-2-93823720"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Australia: UNSW Human Research Ethics Committee", 
                "Australia: Department of Health and Ageing Therapeutic Goods Administration"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Montgomery Asberg Depression Rating Scale for Depression (MADRS)", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01792414"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The University of New South Wales", 
            "investigator_full_name": "Colleen Loo", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Beck Depression Inventory II", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "source": "The University of New South Wales", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The University of New South Wales", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}